Loading organizations...
§ Private Profile · One World Trade Center, NY, NY 10007
Surgical Safety Technologies Inc. is a technology company.
Surgical Safety Technologies Inc. (SST) develops an AI-driven clinical intelligence system capturing and analyzing real-time surgical data. Its OR Black Box® provides unparalleled analytical insights to enhance safety, quality, and operational efficiency within operating rooms. This technology processes complex clinical information, enabling data-driven improvements across surgical environments.
Founded over a decade ago by Dr. Teodor Grantcharov, a visionary surgeon, SST emerged from the insight that modern technologies could improve surgical outcomes. Dr. Grantcharov recognized the critical need for real-time operating room data to drive better decision-making and patient safety, leveraging his expertise to address inherent challenges.
SST's solutions are utilized by health systems to elevate their standard of care. The company’s vision centers on making clinical truth visible by illuminating possibilities through data, partnering with providers to deliver care at its highest potential. It strives to transform healthcare through intelligent software, continuously improving operating room safety and efficiency.
Surgical Safety Technologies Inc. has raised $15.0M across 1 funding round.
Surgical Safety Technologies Inc. has raised $15.0M in total across 1 funding round.
Surgical Safety Technologies Inc. has raised $15.0M across 1 funding round. Most recently, it raised $15.0M Series A in May 2023.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| May 1, 2023 | $15M Series A | Santé Ventures, U.S. Venture Partners | Hanaco Ventures, Munich RE / HSB Ventures, PICO Venture Partners | Announced |
Surgical Safety Technologies Inc. has raised $15.0M in total across 1 funding round.
Surgical Safety Technologies Inc.'s investors include Santé Ventures, U.S. Venture Partners, Hanaco Ventures, Munich Re / HSB Ventures, PICO Venture Partners.
Surgical Safety Technologies Inc. (SST) is a Toronto-based medical technology company that develops the OR Black Box® platform, a comprehensive ambient technology solution combining audiovisual data capture, AI, machine learning, and analytics to enhance patient safety, operational efficiency, and quality in perioperative environments.[1][2][3][4] The platform serves hospitals, trauma centers, simulation centers, and academic healthcare providers across North America and Europe, addressing critical gaps in surgical safety by enabling real-time risk detection, protocol auditing, predictive insights, and process improvements that reduce errors, costs, and complications while improving outcomes.[1][2][5] With nearly 60 employees, $15M in Series A funding raised in 2023, and transformational growth in 2024—including record product adoption and strategic partnerships—SST demonstrates strong momentum toward global scalability.[2][5][6]
SST was founded in 2014 by Teodor Grantcharov, MD, a practicing surgeon in Ontario, Canada, who identified a critical gap in healthcare: unlike aviation's black box for post-event analysis, operating rooms lacked systematic video capture and data-driven review for performance improvement.[3][4] The idea emerged from Grantcharov's own surgeries, where he sought to visually analyze procedures using sensors and data science to replace tradition and bias with objective insights, ultimately aiming to reduce risks and save lives.[1][4] Early traction built through deployments in leading academic centers, backed by high-quality evidence from over 90 peer-reviewed publications, culminating in a $15M Series A round in 2023 led by U.S. Venture Partners and Santé Ventures to fuel automation and commercialization.[2][5]
SST stands out in healthcare technology through its holistic, AI-powered platform tailored for high-stakes clinical environments:
SST rides the wave of AI-driven ambient computing in healthcare, capitalizing on post-pandemic demands for data transparency, value-based care, and operational resilience amid rising surgical volumes and error rates.[1][2][4] Timing aligns with regulatory pushes for quality metrics, clinician burnout solutions, and global surgery equity, amplified by multimodal AI advancements that make scalable analysis feasible.[5][7] Market forces like hospital cost pressures and insurance endorsements favor SST, positioning it to influence ecosystems through clinical trials proving outcome correlations, international partnerships, and benchmarks that standardize safer practices worldwide.[1][5]
SST is primed for accelerated expansion, leveraging 2024's growth in partnerships and adoption to roll out enhanced platform features tied to ongoing clinical trials demonstrating AI's direct patient impact.[1][5] Trends like predictive analytics integration, global health equity initiatives, and regulatory mandates for perioperative data will propel its trajectory, potentially evolving from niche innovator to industry standard-setter.[2][4] As ambient tech paradigms shift care delivery, SST's mission to make clinical truth visible will amplify its role in safer, more efficient healthcare, building directly on its foundational spark in the operating room.[1][4]